# US 2006/0153838 A1 · Fc region variants

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2006/0153838 A1
- Document ID: US20060153838A1
- Status: Published application
- Kind: A1
- Application number: 11/384,134
- Filed: 2006-03-17
- Published: 2006-07-13
- Earliest claimed: 2002-02-20
- Inventors: Jeffry Watkins; Barrett Allan
- Web page: https://patentgrep.com/patent/US20060153838A1

## CPC

- A61K 39/395: Antibodies (agglutinins A61K38/36 {; as drug carriers A61K47/50}); Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61P 31/00: Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P 35/00: Antineoplastic agents
- A61P 37/00: Drugs for immunological or allergic disorders
- C07K 16/00: Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K 16/2896: {against molecules with a "CD"-designation, not provided for elsewhere}
- A61K 2039/505: {comprising antibodies}
- C07K 2317/21: from primates, e.g. man
- C07K 2317/52: Constant or Fc region; Isotype
- C07K 2317/524: CH2 domain
- C07K 2317/72: Increased effector function due to an Fc-modification
- C07K 2317/732: Antibody-dependent cellular cytotoxicity [ADCC]
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)

## Abstract

The present invention provides polypeptide Fc region variants and oligonucleotides encoding Fc region variants. Specifically, the present invention provided compositions comprising novel Fc region variants, methods for identifying useful Fc region variants, and methods for employing Fc region variants for treating disease.

## Claims

### Claim 1

A variant antibody of a parent antibody comprising a human IgG Fc region, which variant comprises an amino acid substitution selected from the group consisting of 294N, 295K, 295L, 296P, 298N, 298V, 298D, 298P, 300I and 300L.

### Claim 2 (depends on 1)

The composition of claim 1, wherein said variant antibody interacts with Fc gamma receptor III (FcγRIII) with a higher binding affinity than said parent antibody.

### Claim 3 (depends on 1)

The variant antibody of claim 1, wherein said variant antibody comprises an unmodified human framework region.

### Claim 4 (depends on 1)

The variant antibody of claim 1, wherein said variant antibody is an anti-CD20 antibody.

### Claim 5 (depends on 1)

The variant antibody claim 1, wherein said parent antibody comprises a human IgG1, IgG2, IgG3, or IgG4 Fc region.

### Claim 6 (depends on 1)

The composition of claim 1, wherein said parent antibody comprises a CH2 region comprising SEQ ID NO:23.
